Takeda Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 7.09% vs 0.55% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 984.41% vs -109.44% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,191,698.00",
          "val2": "1,112,796.00",
          "chgp": "7.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "381,261.00",
          "val2": "317,702.00",
          "chgp": "20.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "123,627.00",
          "val2": "83,138.00",
          "chgp": "48.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "103,733.00",
          "val2": "-11,729.00",
          "chgp": "984.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "160.00%",
          "val2": "101.10%",
          "chgp": "5.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 7.45% vs 5.87% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -25.00% vs -54.52% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,581,551.00",
          "val2": "4,263,762.00",
          "chgp": "7.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,388,939.00",
          "val2": "1,259,425.00",
          "chgp": "10.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "186,976.00",
          "val2": "153,631.00",
          "chgp": "21.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-220,252.00",
          "val2": "-217,776.00",
          "chgp": "-1.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "108,143.00",
          "val2": "144,197.00",
          "chgp": "-25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "137.00%",
          "val2": "124.60%",
          "chgp": "1.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

1,191,698.00

1,112,796.00

7.09%

Operating Profit (PBDIT) excl Other Income

381,261.00

317,702.00

20.01%

Interest

123,627.00

83,138.00

48.70%

Exceptional Items

0.00

0.00

Consolidate Net Profit

103,733.00

-11,729.00

984.41%

Operating Profit Margin (Excl OI)

160.00%

101.10%

5.89%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 7.09% vs 0.55% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 984.41% vs -109.44% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

4,581,551.00

4,263,762.00

7.45%

Operating Profit (PBDIT) excl Other Income

1,388,939.00

1,259,425.00

10.28%

Interest

186,976.00

153,631.00

21.70%

Exceptional Items

-220,252.00

-217,776.00

-1.14%

Consolidate Net Profit

108,143.00

144,197.00

-25.00%

Operating Profit Margin (Excl OI)

137.00%

124.60%

1.24%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 7.45% vs 5.87% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -25.00% vs -54.52% in Mar 2024

All Annual Results